Pacific Biosciences
GenomeWeb Index Takes 7 Percent Tumble in September
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating
PacBio's recent acquisition of Omniome, a short-read sequencing technology firm, is "a true game changer," Canaccord Genuity analyst Kyle Mikson said.
Speedy Long-Read Genome Assembly Enabled by Minimizer-Space Analysis
The minimizer-space de Bruijn graph approach could assemble a human genome in less than 10 minutes using eight cores and 10 gigabytes of random access memory.
ABRF Study Benchmarks NGS Platforms on Human, Microbial Samples, Provides Peek at Genapsys Data
Premium
Illumina's NovaSeq, Oxford Nanopore's Flongle, and Genapsys were among the winners based on the results of the multiyear, multi-center NGS study.
Pacific Biosciences Scores Victory in China in Patent Dispute With Taiwanese Firm
PacBio said it has successfully petitioned for the invalidation of a Chinese patent held by Personal Genomics of Taiwan, which sued the firm for infringing its IP.
Aug 3, 2021
Pacific Biosciences Q2 Revenues Grow 79 Percent
Jul 20, 2021
Apr 30, 2021
Apr 29, 2021
Pacific Biosciences Q1 Revenues Soar 86 Percent
Mar 23, 2021